Dap-ug, Jellfe E.

HRN: 22-12-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2023
AMPICILLIN 1GM (VIAL)
11/26/2023
11/27/2023
IV
2 G
Now Then Q6
PROM; MSAF Thinly
Checking Final Appropriateness 
11/26/2023
CEFUROXIME 1.5GM (VIAL)
11/26/2023
11/27/2023
IV
1.5gms
PTOR
For Stat CS
Checking Final Appropriateness 
11/26/2023
CEFUROXIME 1.5GM (VIAL)
11/26/2023
11/29/2023
IV
1.5 Grams
Q8hrs
S/P Repeat CS
Checking Final Appropriateness 
11/27/2023
CEFUROXIME 500MG (TAB)
11/27/2023
12/04/2023
PO
500mg
BID
SP CS
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: